Summary
Lung function in lymphangioleiomyomatosis (LAM) stabilized and symptoms and quality-of-life improved significantly during treatment with sirolimus, according to results of the Multicenter International LAM Efficacy of Sirolimus [MILES] Trial.
- Pulmonary Clinical Trials
- Lower Respiratory Infections
- © 2011 MD Conference Express
Tools
Multicenter International Lymphangioleiomyomatosis Efficacy and Safety of Sirolimus Trial
Permalink:
Table of contents
Cited By...
- No citing articles found.